SPHACY is formed by three primary keywords: “Technology – Pharmaceutical – Health”. It is through Technology alone that businesses can achieve swift expansion and accelerated sales.
LOGIN
Mar
On November 21, 2024, Mr. Vu Van Thanh, CEO of SPHACY, had the honor of joining the delegation attending the BRICS 2024 Urban Economic Forum in Saint Petersburg, Russia. This event was not only an opportunity for SPHACY to affirm its position in the medical technology sector but also opened up numerous new prospects for [...]
Mar
1. Announcement Details On February 24, 2025, the Department of Health received Decision No. 92/QĐ-QLD from the Drug Administration of Vietnam (DAV) under the Ministry of Health regarding the revocation of marketing authorization for certain drugs in Vietnam. This measure is essential to ensure public safety and maintain quality control over pharmaceuticals in the market. [...]
Jan
The Department of Health has issued Plan No. 406/KH-SYT dated January 10, 2025, regarding post-inspection of GPP (Good Pharmacy Practices). According to this plan, retail pharmacies should be prepared for unexpected inspections by the Department of Health throughout 2025. What is GPP Post-Inspection? GPP post-inspection is the process of conducting on-site inspections at pharmacies to [...]
Jan
The new year is not only a time to embrace opportunities but also a critical moment for pharmacies to complete an essential task: the periodic reporting of special-controlled drugs. This mandatory regulation ensures that the management, use, and circulation of such drugs are conducted transparently and accurately. Report Submission Period: 01/01/2025 – 15/01/2025 Why is [...]
Jan
Spring – the season of new beginnings, hope, and opportunities. Amidst the joyful atmosphere of the new year, SPHACY is delighted to introduce a special promotional program exclusively for pharmacies across the country. This is not only a token of appreciation from SPHACY to our valued customers but also an opportunity for you to upgrade [...]
Distribution Companies
Production companies
GPP Pharmacies
Provinces – Cities
Users
GDP Agents
Mar
On November 21, 2024, Mr. Vu Van Thanh, CEO of SPHACY, had the honor of joining the delegation attending the BRICS 2024 Urban Economic Forum in Saint Petersburg, Russia. This event was not only an opportunity for SPHACY to affirm its position in the medical technology sector but also opened up numerous new prospects for [...]
Mar
1. Announcement Details On February 24, 2025, the Department of Health received Decision No. 92/QĐ-QLD from the Drug Administration of Vietnam (DAV) under the Ministry of Health regarding the revocation of marketing authorization for certain drugs in Vietnam. This measure is essential to ensure public safety and maintain quality control over pharmaceuticals in the market. [...]
Mar
On November 21, 2024, Mr. Vu Van Thanh, CEO of SPHACY, had the honor of joining the delegation attending the BRICS 2024 Urban Economic Forum in Saint Petersburg, Russia. This event was not only an opportunity for SPHACY to affirm its position in the medical technology sector but also opened up numerous new prospects for [...]
Dec
Recently, Vietnam Business Newspaper highlighted SPHACY Joint Stock Company as a prime example of leveraging technology in the pharmaceutical industry, driving innovation and digital transformation in this field. Over the years, Vietnam’s pharmaceutical industry has made significant strides, contributing greatly to the improvement of public health. However, like many other sectors, the pharmaceutical industry faces [...]
16/04/2024
16/04/2024
16/04/2024
16/04/2024
16/04/2024
LOGIN
En
Vi
